Giuseppe Sconocchia

4.4k total citations
88 papers, 2.6k citations indexed

About

Giuseppe Sconocchia is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Giuseppe Sconocchia has authored 88 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Immunology, 34 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Giuseppe Sconocchia's work include Immune Cell Function and Interaction (31 papers), T-cell and B-cell Immunology (23 papers) and Immunotherapy and Immune Responses (16 papers). Giuseppe Sconocchia is often cited by papers focused on Immune Cell Function and Interaction (31 papers), T-cell and B-cell Immunology (23 papers) and Immunotherapy and Immune Responses (16 papers). Giuseppe Sconocchia collaborates with scholars based in Italy, United States and Switzerland. Giuseppe Sconocchia's co-authors include David M. Segal, Nancy F. Hensel, Hiroshi Fujiwara, Adriano Venditti, A. John Barrett, Roberto Arriga, Davide Lauro, Maria Ilaria Del Principe, Katayoun Rezvani and J A Titus and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Giuseppe Sconocchia

86 papers receiving 2.6k citations

Peers

Countries citing papers authored by Giuseppe Sconocchia

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Sconocchia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Sconocchia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Sconocchia more than expected).

Fields of papers citing papers by Giuseppe Sconocchia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Sconocchia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Sconocchia. The network helps show where Giuseppe Sconocchia may publish in the future.

Co-authorship network of co-authors of Giuseppe Sconocchia

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Sconocchia. A scholar is included among the top collaborators of Giuseppe Sconocchia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Sconocchia. Giuseppe Sconocchia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer 2025 ·Cancer Cell International ·Hany E. Marei, (unknown), Anwarul Hasan, Layla Al-Mansoori, Sara Caratelli, Giuseppe Sconocchia, (unknown), Carlo Cenciarelli	8
2	Local therapy in glioma: An evolving paradigm from history to horizons (Review) 2024 ·Oncology Letters ·Tamara Ius, Teresa Somma, Francesco Pasqualetti, (unknown), (unknown), (unknown), (unknown), Carlo Cenciarelli, Giacomo Pozzoli, Giuseppe Sconocchia, Marco Zeppieri, (unknown), Maria Caffo, Giuseppe Lombardi	4
3	Impact of HLA Class I Antigen, Killer Inhibitory Receptor, andFCGR3A Genotypes on Breast Cancer Susceptibility and TumorStage 2023 ·Current Molecular Medicine ·A. Canossi, Anna Aureli, Tiziana Del Beato, Giorgio Novelli, Oreste Claudio Buonomo, P Rossi, Adriano Venditti, F. Papola, Giuseppe Sconocchia	2
4	Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond 2023 ·Cancers ·Anna Aureli, (unknown), Adriano Venditti, Tommaso Sconocchia, Giuseppe Sconocchia	14
5	Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma 2022 ·Frontiers in Oncology ·(unknown), (unknown), Raffaele Palmieri, (unknown), Maria Rosaria Pascale, (unknown), (unknown), Francesco Buccisano, Maria Teresa Voso, Luca Maurillo, Giuseppe Sconocchia, Adriano Venditti, Maria Ilaria Del Principe	0
6	Pulmonary function testing for fitness assessment in asymptomatic adults with newly diagnosed acute myeloid leukemia 2022 ·Haematologica ·Raffaele Palmieri, Megan Othus, Guang‐Shing Cheng, Francesco Buccisano, Giovangiacinto Paterno, Luca Maurillo, Maria Ilaria Del Principe, Giuseppe Sconocchia, Adriano Venditti, Roland B. Walter	1
7	Recent perspective on CAR and Fcγ-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes 2019 ·Biochemical Pharmacology ·Hany E. Marei, Asma Al-Thani, Thomas Caceci, Roberto Arriga, Tommaso Sconocchia, Alessio Ottaviani, Giulia Lanzilli, Mario Roselli, Sara Caratelli, Carlo Cenciarelli, Giuseppe Sconocchia	19
8	FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance 2017 ·Frontiers in Immunology ·Sara Caratelli, Tommaso Sconocchia, Roberto Arriga, Andrea Coppola, Giulia Lanzilli, Davide Lauro, Adriano Venditti, Maria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, Soldano Ferrone, Giuseppe Sconocchia	46
9	Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage 2016 ·Journal of Translational Medicine ·A. Canossi, Anna Aureli, Tiziana Del Beato, P Rossi, Luana Franceschilli, (unknown), Pierpaolo Sileri, Nicola Di Lorenzo, Oreste Claudio Buonomo, Davide Lauro, Adriano Venditti, Giuseppe Sconocchia	9
10	T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G–opsonized target cells 2015 ·Cytotherapy ·(unknown), Sara Caratelli, Camilla Palumbo, Simone Battella, Roberto Arriga, Davide Lauro, Gabriella Palmieri, Giuseppe Sconocchia, Maurizio Alimandi	43
11	Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients 2015 ·Annals of Hematology ·Francesco Buccisano, Luca Maurillo, Alfonso Piciocchi, Maria Ilaria Del Principe, Chiara Sarlo, Mariagiovanna Cefalo, (unknown), Ambra Di Veroli, (unknown), Maria Irno Consalvo, Daniela Fraboni, Paola Panetta, Patrizia Palomba, (unknown), Giovanni Del Poeta, Giuseppe Sconocchia, Francesco Lo‐Coco, Sergio Amadori, Adriano Venditti	22
12	CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY 2014 ·Mediterranean Journal of Hematology and Infectious Diseases ·Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Giuseppe Sconocchia, Mariagiovanna Cefalo, (unknown), Ambra Di Veroli, (unknown), (unknown), Massimiliano Postorino, (unknown), (unknown), Giovanni Del Poeta, Sergio Amadori, Adriano Venditti	38
13	NK cells and T cells cooperate during the clinical course of colorectal cancer 2014 ·OncoImmunology ·Giuseppe Sconocchia, (unknown), Giulio C. Spagnoli, Luigi Tornillo, Raoul A. Droeser, Sara Caratelli, Francesca Ferrelli, Andrea Coppola, Roberto Arriga, Davide Lauro, Giandomenica Iezzi, Luigi Terracciano, Soldano Ferrone	117
14	Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia 2011 ·Blood ·Francesco Buccisano, Luca Maurillo, Maria Ilaria Del Principe, Giovanni Del Poeta, Giuseppe Sconocchia, Francesco Lo‐Coco, William Arcese, Sergio Amadori, Adriano Venditti	185
15	Defective Infiltration of Natural Killer Cells in MICA/B-Positive Renal Cell Carcinoma Involves β2-Integrin-Mediated Interaction 2009 ·Neoplasia ·Giuseppe Sconocchia, Giulio C. Spagnoli, Domenico Del Principe, Soldano Ferrone, Maurizio Anselmi, (unknown), Valerio Cervelli, Elke Schultz‐Thater, Stephen Wyler, Vincenza Carafa, Holger Moch, Luigi Terracciano, Luigi Tornillo	53
16	Phenotype and function of a CD56+ peripheral blood monocyte 2004 ·Leukemia ·Giuseppe Sconocchia, Keyvan Keyvanfar, Frank El Ouriaghli, Matthias Grube, Katayoun Rezvani, Hiroshi Fujiwara, J. Philip McCoy, Nancy F. Hensel, A. John Barrett	45
17	Cutting Edge: HIV-1 Infection Induces a Selective Reduction in STAT5 Protein Expression 1998 ·The Journal of Immunology ·Federica Pericle, Lígia A. Pinto, Stuart W. Hicks, Robert A. Kirken, Giuseppe Sconocchia, Janice M. Rusnak, Matthew J. Dolan, Gene M. Shearer, David M. Segal	46
18	Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes 1997 ·The Journal of Immunology ·Federica Pericle, Robert A. Kirken, Vincenzo Bronte, Giuseppe Sconocchia, Luis L. P. daSilva, David M. Segal	41
19	Alternative Triggering Molecules and Single Chain Bispecific Antibodies 1995 ·Journal of Hematotherapy ·David M. Segal, Giuseppe Sconocchia, J A Titus, Carolina R. Jost, I. Kurucz	8
20	Polymorphic effects of exogenous gangliosides on antigen-induced lymphoproliferation and generation of MHC unrestricted cell mediated cytotoxicity 1990 ·International Journal of Immunopharmacology ·Giulio C. Spagnoli, Clara Maria Ausiello, Giuseppe Sconocchia, Guido Antonelli, Carla Amici, Carlo Umberto Casciani	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact